I'd go one step further. Give the FDA competition. Have private companies (similar to UL for electronics) that can endorse and test drugs.
I'd go one step further. Give the FDA competition. Have private companies (similar to UL for electronics) that can endorse and test drugs.
Do you also only blame the police for not catching a criminal, and not care about the criminal at all?
The ratings agencies actively marked bonds as AA which they knew darn well were in reality B or worse. They committed fraud at the behest of the banks.
There is a massive difference between inaction and fraud. That's why the SEC doesn't get a lot of blame.
You can argue that no rational company that cares about its reputation would do such a thing, but history has shown time and time again - yes corporations do waive all consideration for public safety in lieu for money.
The government is the perfect institution to endorse safety of substances/drugs/whatever for use by it's citizens. That doesn't mean they are perfect though, but I would trust them a thousand times more than a corporation.
It's extremely wreckless to apply free market economic theories to things like this. In the real world, consumers and businesses are irrational.
Outright bribery in the US is rare, difficult, and if caught, will land you in federal prison for a long time. Remember Blagojevich?
Government officials are under much more scrutiny than a private sector executive. There are independent investigators general that have broad latitude to look for malfeasance. The FOIA exists to bring government records to light; there is no equivalent in the private sector. Heck, we spent ~$80mm investigating Clinton over the Lewinsky affair.
The government isn't perfect, but it's a damn sight more transparent and directly accountable to the public than private companies are.
If the European/Japanese/Other Reputable Country authorities have approved a drug, it could be allowed it in the US, with a clear label, of course.
Foreign physiology and science is the same as American.
Experts estimate that the drug thalidomide led to the death of approximately 2,000 children and serious birth defects in more than 10,000 children, about 5,000 of them in West Germany.
While within a country a given barrier may be too high or low, it will probably be somewhat randomly too high or low around some appropriate level of safety. With the multi-country scheme, the bias will be towards too low on nearly every drug.
I was proposing something like UL which is independent from the companies being overseen.
Because that worked so well with risk analysis in finance. 2008 is calling.